PerioRinse (CENTURA PHARMACEUTICALS INC)


Welcome to the PulseAid listing for the PerioRinse drug offered from CENTURA PHARMACEUTICALS INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.

LABELER NAME / MANUFACTURER: CENTURA PHARMACEUTICALS INC
NON-PROPRIETARY NAME: DYCLONINE
SUBSTANCE NAME: DYCLONINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: DENTAL; ORAL; TOPICAL; TRANSMUCOSAL
DOSAGE FORM: RINSE
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2016-06-16
END MARKETING DATE: 0000-00-00


PerioRinse HUMAN OTC DRUG Details:

Item DescriptionPerioRinse from CENTURA PHARMACEUTICALS INC
LABELER NAME: CENTURA PHARMACEUTICALS INC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.1(g/100mL)
START MARKETING DATE: 2016-06-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70372-726_34385375-1c3e-5ecd-e054-00144ff8d46c
PRODUCT NDC: 70372-726
APPLICATION NUMBER: part356

Other DYCLONINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
CENTURA PHARMACEUTICALS INCPerioRinse
Insight PharmaceuticalsSucrets
Insight Pharmaceuticals LLCSucrets